Literature DB >> 20212952

Prevention and therapy of bacterial infections for children with asplenia or hyposplenia.

.   

Abstract

The asplenic state, whether functional or anatomic, is associated with an increased risk of life threatening infection or postsplenectomy sepsis (PSS). Because the risk of bacteremia with encapsulated bacteria is enhanced in children with asplenia, vaccination to prevent infection by Streptococcus pneumoniae, Haemophilus influenzae type b (Hib) and Neiserria meningitidis is recommended. Despite the increasing prevalence of penicillin-resistant S pneumoniae, prophylactic penicillin use is also recommended for children with asplenia who are younger than five years of age, and for at least one year following splenectomy. Continuation of antibiotic prophylaxis beyond these times depends on individual clinical circumstances and the prevalence of penicillin-resistant S pneumoniae in the community. When children with asplenia develop fever or nonspecific symptoms, they should be assessed immediately. If bacterial sepsis is suspected, blood and other appropriate body fluids should be cultured, and treatment should begin immediately with parenteral broad spectrum antibiotics that are also effective against the strains of S pneumoniae circulating in the community. In children with asplenia with overwhelming S pneumoniae bacteremia, the mortality rate is high, even with prompt initiation of appropriate antibiotic therapy. Thus, preventive measures are important.

Entities:  

Keywords:  Asplenia; Hyposplenia

Year:  1999        PMID: 20212952      PMCID: PMC2827744          DOI: 10.1093/pch/4.6.417

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  30 in total

1.  Incidence of infection in children after splenectomy.

Authors:  B LASKI; A MACMILLAN
Journal:  Pediatrics       Date:  1959-10       Impact factor: 7.124

2.  Splenic studies.

Authors:  H B SHUMACKER; H KING
Journal:  AMA Arch Surg       Date:  1952-10

3.  Effect of splenectomy on the expression of regulatory T cell activity.

Authors:  D F Amsbaugh; B Prescott; P J Baker
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae.

Authors:  J A Coil; J D Dickerman; E Boulton
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

5.  Defective phagocytosis due to tuftsin deficiency in splenectomized subjects.

Authors:  A Constantopoulos; V A Najjar; J B Wish; T H Necheles; L L Stolbach
Journal:  Am J Dis Child       Date:  1973-05

6.  The hazard of infection following splenectomy in children.

Authors:  W D Erickson; E O Burgert; H B Lynn
Journal:  Am J Dis Child       Date:  1968-07

7.  The effect of previous splenectomy on the course of pneumococcal bacteriaemia in mice.

Authors:  A N Whitaker
Journal:  J Pathol Bacteriol       Date:  1968-04

8.  Hazard of severe infections in splenectomized infants and children.

Authors:  C H SMITH; M ERLANDSON; I SCHULMAN; G STERN
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

9.  Infectior following splenectomy in infants and children.

Authors:  A D FORWARD; P G ASHMORE
Journal:  Can J Surg       Date:  1960-04       Impact factor: 2.089

10.  Immune response after splenectomy.

Authors:  J L Sullivan; H D Ochs; G Schiffman; M R Hammerschlag; J Miser; E Vichinsky; R J Wedgwood
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

View more
  8 in total

1.  Questions and answers on immunization.

Authors:  David Scheifele; Simon Dobson
Journal:  Paediatr Child Health       Date:  2005-09       Impact factor: 2.253

2.  Prophylactic antibiotics in children.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-10       Impact factor: 2.253

Review 3.  Treatment of immune thrombocytopenic purpura in children : current concepts.

Authors:  Aziza T Shad; Corina E Gonzalez; S G Sandler
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children.

Authors:  B Mikoluc; H Kayhty; E Bernatowska; R Motkowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

5.  Enhanced Bacteremia in Dextran Sulfate-Induced Colitis in Splenectomy Mice Correlates with Gut Dysbiosis and LPS Tolerance.

Authors:  Arthid Thim-Uam; Jiradej Makjaroen; Jiraphorn Issara-Amphorn; Wilasinee Saisorn; Dhammika Leshan Wannigama; Wiwat Chancharoenthana; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

6.  Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study.

Authors:  Timothy M Rawson; Richard C Wilson; Luke S P Moore; Alasdair P Macgowan; Andrew M Lovering; Mark Bayliss; Mathew Kyriakides; Mark Gilchrist; Jason A Roberts; William W Hope; Alison H Holmes
Journal:  Open Forum Infect Dis       Date:  2021-12-18       Impact factor: 3.835

7.  Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Sandra Regina Loggetto; Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Wanderley Marques Bernardo; Leticia Medeiros; Andrea Thives de Carvalho Hoepers
Journal:  Rev Bras Hematol Hemoter       Date:  2013

8.  Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood.

Authors:  Raffaella Colombatti; Silverio Perrotta; Piera Samperi; Maddalena Casale; Nicoletta Masera; Giovanni Palazzi; Laura Sainati; Giovanna Russo
Journal:  Orphanet J Rare Dis       Date:  2013-10-20       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.